AAAAAA

   
Results: 1-15 |
Results: 15
A PHASE-III STUDY EVALUATING CD34(-BLOOD PROGENITOR-CELL TRANSPLANTATION FOR PATIENTS WITH ADVANCED MULTIPLE-MYELOMA - ENGRAFTMENT RESULTS() SELECTED VERSUS UNSELECTED AUTOLOGOUS PERIPHERAL)
Authors: SCHILLER G STEWART AK BALLESTER O NOGA S RUGO H FREYTES C STADTMAUER E KOGUT N TARANFOLO S STIFF P PINEIRO L DALTON W HO A VESCIO R BENYUNES M JACOBS C DIPERSIO J ANDERSON K BERENSON J
Citation: G. Schiller et al., A PHASE-III STUDY EVALUATING CD34(-BLOOD PROGENITOR-CELL TRANSPLANTATION FOR PATIENTS WITH ADVANCED MULTIPLE-MYELOMA - ENGRAFTMENT RESULTS() SELECTED VERSUS UNSELECTED AUTOLOGOUS PERIPHERAL), Blood, 90(10), 1997, pp. 960-960
MYELOMA CELL TUMOR REDUCTION IN PBPC AUTOGRAFTS FOLLOWING CD34 SELECTION - THE RESULTS OF A PHASE-III TRIAL USING THE CEPRATE DEVICE
Authors: VESCIO R STEWART A BALLESTER O NOGA S RUGO H FREYTES C STADTMAUER E KOGUT N TARANTOLO S STIFF P PINERO L DALTON W HO A SCHILLER G BENYUNES M JACOBS C DIPERSIO J ANDERSON K BERENSON J
Citation: R. Vescio et al., MYELOMA CELL TUMOR REDUCTION IN PBPC AUTOGRAFTS FOLLOWING CD34 SELECTION - THE RESULTS OF A PHASE-III TRIAL USING THE CEPRATE DEVICE, Blood, 90(10), 1997, pp. 1872-1872
INCREASE IN CIRCULATING TUMOR-CELL BURDEN DURING MOBILIZATION CHEMOTHERAPY PREDICTS FOR RELAPSE AFTER AUTOLOGOUS TRANSPLANTATION IN MULTIPLE-MYELOMA PATIENTS
Authors: VESCIO R STEWART A BALLESTER O NOGA S RUGO H FREYTES C STADTMAUER E KOGUT N TARANTOLO S STIFF P PINERO L DALTON W HO A SCHILLER G BENYUNES M JACOBS C DIPERSIO J ANDERSON K BERENSON J
Citation: R. Vescio et al., INCREASE IN CIRCULATING TUMOR-CELL BURDEN DURING MOBILIZATION CHEMOTHERAPY PREDICTS FOR RELAPSE AFTER AUTOLOGOUS TRANSPLANTATION IN MULTIPLE-MYELOMA PATIENTS, Blood, 90(10), 1997, pp. 2515-2515
THE DETECTION OF KSHV IS INCREASED BY MOBILIZATION CHEMOTHERAPY AND REDUCED IN AUTOGRAFTS BY CD34-SELECTION
Authors: VESCIO R WU C RETTIG M STEWART A BALLESTER O NOGA S RUGO H FREYTES C STADTMAUER E KOGUT N TARANTOLO S STIFF P PINERO L DALTON W HO A SCHILLER G BENYUNES M JACOBS C DIPERSIO J ANDERSON K BERENSON J
Citation: R. Vescio et al., THE DETECTION OF KSHV IS INCREASED BY MOBILIZATION CHEMOTHERAPY AND REDUCED IN AUTOGRAFTS BY CD34-SELECTION, Blood, 90(10), 1997, pp. 2516-2516
TREATING HUMAN MYELOGENOUS LEUKEMIA WITH C-MYB ANTISENSE OLIGODEOXYNUCLEOTIDES - 2 YEARS CLINICAL-EXPERIENCE
Authors: GEWIRTZ AM LUGER S SOKOL D GOWDIN B STADTMAUER E RECCIO A RATAJCZAK MZ
Citation: Am. Gewirtz et al., TREATING HUMAN MYELOGENOUS LEUKEMIA WITH C-MYB ANTISENSE OLIGODEOXYNUCLEOTIDES - 2 YEARS CLINICAL-EXPERIENCE, Journal of investigative medicine, 44(3), 1996, pp. 279-279
BONE-MARROW PURGING WITH OLIGODEOXYNUCLEOTIDES
Authors: GEWITZ AM LUGER SM STADTMAUER E
Citation: Am. Gewitz et al., BONE-MARROW PURGING WITH OLIGODEOXYNUCLEOTIDES, Blood, 88(4), 1996, pp. 1517-1517
A PHASE-II TRIAL OF FILGRASTIM (G-CSF) SUPPORTED HIGH-DOSE SEQUENTIALCHEMOTHERAPY AND PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANTATION ASINITIAL THERAPY FOR HIGH-RISK NON-HODGKINS LYMPHOMA(NHL) - A MULTICENTER PILOT-STUDY
Authors: SCHENKEIN DP ROITMAN D MILLER KB MORELLI J STADTMAUER E PECORA AL CASSILETH P LAZARUS HM
Citation: Dp. Schenkein et al., A PHASE-II TRIAL OF FILGRASTIM (G-CSF) SUPPORTED HIGH-DOSE SEQUENTIALCHEMOTHERAPY AND PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANTATION ASINITIAL THERAPY FOR HIGH-RISK NON-HODGKINS LYMPHOMA(NHL) - A MULTICENTER PILOT-STUDY, Blood, 88(10), 1996, pp. 462-462
OLIGODEOXYNUCLEOTIDE THERAPEUTICS FOR HUMAN MYELOGENOUS LEUKEMIA - INTERIM RESULTS
Authors: GEWIRTZ AM LUGER S SOKOL D GOWDIN B STADTMAUER E RECCIO A RATAJCZAK MZ
Citation: Am. Gewirtz et al., OLIGODEOXYNUCLEOTIDE THERAPEUTICS FOR HUMAN MYELOGENOUS LEUKEMIA - INTERIM RESULTS, Blood, 88(10), 1996, pp. 1069-1069
DANAZOL TREATMENT OF MYELODYSPLASIA
Authors: STADTMAUER E
Citation: E. Stadtmauer, DANAZOL TREATMENT OF MYELODYSPLASIA, Gematologia i transfuziologia, 40(2), 1995, pp. 14-14
A PHASE-II TRIAL OF FILGRASTIM (G-CSF) SUPPORTED HIGH-DOSE SEQUENTIALCHEMOTHERAPY AND PERIPHERAL BOOD STEM-CELL (PBSC) TRANSPLANTATION AS INITIAL THERAPY FOR HIGH-RISK NON-HODSKINS LYMPHOMA(NHL) - A MULTICENTER PILOT-STUDY
Authors: SCHENKEIN DP MILLER KB SWEET M ROSENBACH M STADTMAUER E CASSILETH P COOPER B LAZARUS HM
Citation: Dp. Schenkein et al., A PHASE-II TRIAL OF FILGRASTIM (G-CSF) SUPPORTED HIGH-DOSE SEQUENTIALCHEMOTHERAPY AND PERIPHERAL BOOD STEM-CELL (PBSC) TRANSPLANTATION AS INITIAL THERAPY FOR HIGH-RISK NON-HODSKINS LYMPHOMA(NHL) - A MULTICENTER PILOT-STUDY, Blood, 86(10), 1995, pp. 3844-3844
CYCLOPHOSPHAMIDE (CYT) ENHANCES G-CSF MOBILIZED CD34-BLOOD PROGENITOR-CELL (PSC) COLLECTION IN PATIENTS WITH RESPONDING METASTATIC BREAST-CANCER (MBC) AT THE EXPENSE OF INCREASED TOXICITY AND COST( PERIPHERAL)
Authors: STADTMAUER E LUGER S BIRD J MANGAN P SICKLES C GAULT E MAGEE D SILBERSTEIN L
Citation: E. Stadtmauer et al., CYCLOPHOSPHAMIDE (CYT) ENHANCES G-CSF MOBILIZED CD34-BLOOD PROGENITOR-CELL (PSC) COLLECTION IN PATIENTS WITH RESPONDING METASTATIC BREAST-CANCER (MBC) AT THE EXPENSE OF INCREASED TOXICITY AND COST( PERIPHERAL), Blood, 86(10), 1995, pp. 3953-3953
BCL-2 GENE HYPOMETHYLATION AND HIGH-LEVEL EXPRESSION IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: HANADA M DELIA D AIELLO A STADTMAUER E REED JC
Citation: M. Hanada et al., BCL-2 GENE HYPOMETHYLATION AND HIGH-LEVEL EXPRESSION IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA, Blood, 82(6), 1993, pp. 1820-1828
GM-CSF MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS (PSC) AND GM-CSF POST INFUSION AFTER HIGH-DOSE MELPHALAN, CYCLOPHOSPHAMIDE AND TOTAL-BODY IRRADIATION (TBI) FOR ADVANCED RELAPSED MULTIPLE-MYELOMA
Authors: STADTMAUER E SCHENKEIN D MILLER K SICKLES C BIGGS D POWLIS W FRIEDENBERG W WINTER J TALLMAN M LAZARUS H
Citation: E. Stadtmauer et al., GM-CSF MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS (PSC) AND GM-CSF POST INFUSION AFTER HIGH-DOSE MELPHALAN, CYCLOPHOSPHAMIDE AND TOTAL-BODY IRRADIATION (TBI) FOR ADVANCED RELAPSED MULTIPLE-MYELOMA, Blood, 82(10), 1993, pp. 10000264-10000264
COMBINED RG-CSF AND GM-CSF PRIMING OF PERIPHERAL-BLOOD STEM-CELL HARVESTS
Authors: WINTER JN MANGAN C BYRD K TALLMAN M GORDON L JAHNKE L LAZARUS H COOPER B CRUM E HORVATH N STADTMAUER E RADEMAKER A VILLA M CONKLIN E MARTIN J GOOLSBY C OGORMAN M
Citation: Jn. Winter et al., COMBINED RG-CSF AND GM-CSF PRIMING OF PERIPHERAL-BLOOD STEM-CELL HARVESTS, Blood, 82(10), 1993, pp. 10000293-10000293
RAPID RECOVERY OF ACTIVATED T-CELLS AND NK CELLS FOLLOWING PERIPHERALSTEM-CELL TRANSPLANTATION IN METASTATIC BREAST-CANCER
Authors: BIGGS D DOUGLAS R FRAZIER D TARSKIS A MANGAN P SILBERSTEIN L STADTMAUER E MOORE J
Citation: D. Biggs et al., RAPID RECOVERY OF ACTIVATED T-CELLS AND NK CELLS FOLLOWING PERIPHERALSTEM-CELL TRANSPLANTATION IN METASTATIC BREAST-CANCER, Blood, 82(10), 1993, pp. 10000645-10000645
Risultati: 1-15 |